← Back to the biomarker database

Enterococcus faecalis: the pathway in the body

Enterococcus faecalis is part of the pathway “Gut bacteria”. This page shows the whole pathway; the station of Enterococcus faecalis is highlighted.

Where this laboratory value sits: Enterococcus faecalis — lactic acid bacterium. Enterococcus faecalis lives in small numbers in the gut. It grows with and without oxygen, tolerates bile and salt and ferments sugars almost entirely to lactic acid (lactate). It is naturally insensitive to cephalosporins. Source 11

In brief

Gut bacteria such as bifidobacteria, lactobacilli, Faecalibacterium and Akkermansia live mainly in the large intestine. They ferment dietary fibre and mucus sugars into short-chain fatty acids such as acetate, propionate and butyrate, which gut cells use as fuel and signal.

13 stations · 13 sources
ORYColonic fermentationAt the gut wallGlycosidasesButyryl-CoA transf.β-oxidationMCT transporterMucin glycosidasesIngested bacteriafrom food or preparationsBifidobacteriumBifidobacteriaLactobacillusLactic acid bacteriaFaecalibacteriumF. prausnitziiDietary fibreindigestible carbohydratesLactate and acetatefirst fermentation productsButyrateshort-chain fatty acidGut wall cellsColonocytesAkkermansiaA. muciniphilaMucus (mucin)Layer over the gut wallAcetate and propionatefrom the sugar chainsFFAR2 and FFAR3Receptors on the cellsEnterococcus faecalislactic acid bacterium

Swipe the graphic sideways

The pathway step by step

Each station states what the compound does there. Three signs: ↑ supplies — builds up or makes available · ↓ depletes — inhibits, consumes or withholds · ↕ both, depending on amount. Behind it stands what the statement rests on: established physiology, observed in studies, or contested. The signs do not grade; they name the direction.

  1. Dietary fibre → Lactate and acetate Glycosidases Bacterial glycosidases split the long chains into sugar units; fermentation yields lactic acid, acetate and gases. Other species absorb these intermediates. Source 1, 2↑ supplies Lactate and acetate are intermediates that bacteria pass among themselves: butyrate producers absorb acetate, and lactate users turn lactate into butyrate or propionate. established physiology Source 1, 2
    ⚖ When the balance tips

    too much — If more lactate is left over than the lactate users can absorb, it accumulates in the gut contents and lowers the pH.

    too little — If little acetate is present, butyrate producers such as Faecalibacterium have less starting material for the final step.

    observed in studies · Source 1, 5

  2. Lactate and acetate → Butyrate Butyryl-CoA transf. Butyrate producers use acetate and lactate from their neighbours; this handing-on is called cross-feeding. The enzyme butyryl-CoA:acetate CoA-transferase carries out the final step. If little acetate is present, less butyrate is formed. Source 1, 5↑ supplies Butyrate is the end product of cross-feeding and supplies fuel to the colon cells. A monocarboxylate transporter carries it into the cell. established physiology Source 3, 1
    ⚖ When the balance tips

    too much — If more butyrate is present than the colon cells burn, part of it reaches the liver via the portal vein.

    too little — If little butyrate is present, for example because little acetate and lactate are passed on, less of it reaches the gut wall.

    established physiology · Source 3, 1, 5

  3. Butyrate → Gut wall cells β-oxidation · MCT transporter The cells of the colonic lining absorb butyrate and burn it in their mitochondria. It covers a large part of their energy needs. Butyrate left over acts as a signal in the nucleus. Source 3, 1↑ supplies In the colon cells, butyrate is turned into energy via β-oxidation. What is not burned inhibits histone deacetylases in the cell nucleus and so changes which genes are read. observed in studies Source 3
    ⚖ When the balance tips

    too much — If more butyrate is left in the cell than it burns, it inhibits histone deacetylases more strongly and alters the reading of genes. This is described mainly in cell culture.

    too little — If little butyrate arrives, the colon cells burn less of it and rely more on other fuels.

    observed in studies · Source 3, 1

  4. Mucus (mucin) → Acetate and propionate Mucin glycosidases Breaking down the mucin sugar chains produces acetate and propionate. Other species nearby make further use of these substances. Propionate is used mainly in the liver. Source 4, 1↑ supplies Acetate and propionate enter the blood: propionate is used mainly in the liver, while acetate also reaches other tissues. Via FFAR2 and FFAR3 both also act as signals. established physiology Source 3, 1
    ⚖ When the balance tips

    too much — If a lot of acetate and propionate is formed, the pH of the gut contents drops, and more of them reaches the liver via the portal vein.

    too little — If little of them is formed, FFAR2 and FFAR3 are occupied less often, and butyrate producers receive less acetate.

    established physiology · Source 3, 1

  5. Acetate and propionate → FFAR2 and FFAR3 Acetate and propionate bind to the receptors FFAR2 and FFAR3 on gut, fat and immune cells. Through them they act as signalling molecules, not just as fuel. Occupied receptors trigger the release of gut hormones. Source 3↑ supplies Occupied FFAR2 and FFAR3 trigger signals in the cell: hormone-producing gut cells release GLP-1 and PYY, and immune cells change their response. Much of this comes from animal models. observed in studies Source 3
    ⚖ When the balance tips

    too much — If many receptors are occupied, the hormone-producing gut cells release more GLP-1 and PYY. This is described mainly in animal models and cell culture.

    too little — If the receptors are rarely occupied, these signals become weaker; mice without FFAR2 or FFAR3 show altered hormone and immune responses.

    observed in studies · Source 3

Further stations

Cofactors in this pathway

Sources

  1. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017 · PubMed 27928878
  2. Rivière A, Selak M, Lantin D et al. Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. Front Microbiol 2016 · PubMed 27446020
  3. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell 2016 · PubMed 27259147
  4. Ioannou A, Berkhout MD, Scott WT et al. Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential. Nat Rev Microbiol 2025 · PubMed 39406893
  5. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009 · PubMed 19222573
  6. Suzuki R, Katayama T, Kim BJ et al. Crystal structures of phosphoketolase: thiamine diphosphate-dependent dehydration mechanism. J Biol Chem 2010 · PubMed 20739284
  7. Buckel W, Thauer RK. Flavin-Based Electron Bifurcation, A New Mechanism of Biological Energy Coupling. Chem Rev 2018 · PubMed 29561602
  8. Belzer C, Chia LW, Aalvink S et al. Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts. mBio 2017 · PubMed 28928206
  9. Zmora N, Zilberman-Schapira G, Suez J et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell 2018 · PubMed 30193112
  10. Hill C, Guarner F, Reid G et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014 · PubMed 24912386
  11. García-Solache M, Rice LB. The Enterococcus: a Model of Adaptability to Its Environment. Clin Microbiol Rev 2019 · PubMed 30700430
  12. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002 · PubMed 11895869
  13. Ubeda C, Taur Y, Jenq RR et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010 · PubMed 21099116

Whole pathway: Gut bacteria

Related pathways

As of 2026-09-16. Draft written by Claude to schema v2; sources checked in PubMed; expert review pending
Legal notice Privacy policy All biomarkers